AtriCure, Inc.
AtriCure, Inc.（ATRC）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ATRC · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
12
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
AtriCure, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ATRC 季度内部人买卖趋势
ATRC 内幕交易卖出 · ATRC 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ATRC CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ATRC 高管卖出股份 · ATRC 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 20, 2026 | Prange Karen Director | Sale | 3,000 | $86K | Form 4 |
| May 18, 2026 | Prange Karen Director | Award | 6,144 | — | Form 4 |
| May 18, 2026 | Telman Deborah H Director | Award | 6,144 | — | Form 4 |
| May 18, 2026 | Yuen Maggie Director | Award | 6,144 | — | Form 4 |
| May 18, 2026 | Nachman Shlomo Director | Award | 6,144 | — | Form 4 |
| May 18, 2026 | JOHNSON B KRISTINE Director | Award | 6,144 | — | Form 4 |
| May 18, 2026 | GROVES REGINA E Director | Award | 6,144 | — | Form 4 |
| May 18, 2026 | WEHRWEIN SVEN Director | Award | 6,144 | — | Form 4 |
| May 18, 2026 | WHITE ROBERT S. Director | Award | 6,144 | — | Form 4 |
| May 15, 2026 | Doraiswamy Vinayak Chief Scientific Officer | Sale | 5,000 | $141K | Form 4 |
| Mar 12, 2026 | Doraiswamy Vinayak Chief Scientific Officer | Sale | 5,000 | $149K | Form 4 |
| Mar 10, 2026 | WHITE ROBERT S. Director | Option | 10,000 | $150K | Form 4 |
| Mar 6, 2026 | CARREL MICHAEL H President, CEO, & Director | Gift | 5,000 | — | Form 4 |
| Mar 6, 2026 | CARREL MICHAEL H President, CEO, & Director | Gift | 1,000 | — | Form 4 |
| Mar 1, 2026 | CARREL MICHAEL H President, CEO, & Director | Award | 101,280 | — | Form 4 |
| Mar 1, 2026 | CARREL MICHAEL H President, CEO, & Director | Other | 72,777 | $2.28M⚡ | Form 4 |
| Mar 1, 2026 | CARREL MICHAEL H President, CEO, & Director | Award | 68,618 | — | Form 4 |
| Mar 1, 2026 | Noznesky Justin J Chief Mktg & Strategy Officer | Award | 15,198 | — | Form 4 |
| Mar 1, 2026 | Noznesky Justin J Chief Mktg & Strategy Officer | Award | 27,991 | — | Form 4 |
| Mar 1, 2026 | Noznesky Justin J Chief Mktg & Strategy Officer | Other | 15,586 | $487K | Form 4 |
| Mar 1, 2026 | Privitera Salvatore Chief Technical Officer | Award | 15,198 | — | Form 4 |
| Mar 1, 2026 | Privitera Salvatore Chief Technical Officer | Other | 13,127 | $410K | Form 4 |
| Mar 1, 2026 | Privitera Salvatore Chief Technical Officer | Award | 30,390 | — | Form 4 |
| Mar 1, 2026 | Doraiswamy Vinayak Chief Scientific Officer | Award | 15,198 | — | Form 4 |
| Mar 1, 2026 | Doraiswamy Vinayak Chief Scientific Officer | Award | 30,390 | — | Form 4 |
CARREL MICHAEL H
President, CEO, & Director
日期
Mar 1
股数
72,777
均价
$31.26
总金额
$2.28M ⚡
Noznesky Justin J
Chief Mktg & Strategy Officer
日期
Mar 1
股数
15,586
均价
$31.26
总金额
$487K
Privitera Salvatore
Chief Technical Officer
日期
Mar 1
股数
13,127
均价
$31.26
总金额
$410K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ATRC 内幕交易
ATRC 内幕交易
AtriCure, Inc.（ATRC）内幕交易数据来源于公司内部人（包括WEHRWEIN SVEN (Director), CARREL MICHAEL H (President, CEO, & Director), Doraiswamy Vinayak (Chief Scientific Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ATRC内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看AtriCure, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ATRC 内幕交易 · 5个问题AtriCure, Inc.（ATRC）的内部人包括高管和董事，如WEHRWEIN SVEN (Director), CARREL MICHAEL H (President, CEO, & Director), Doraiswamy Vinayak (Chief Scientific Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026